No headlines found.
Complete Genomics Appoints Lauren Selig to Board of Directors
Business Wire (Wed, 19-Aug 9:00 AM ET)
Renatus Tactical Acquisition Corp I is a blank check company.
Renatus Tactical Acquisition I - Class A trades on the NASDAQ stock market under the symbol RTAC.
As of September 10, 2026, RTAC stock price declined to $10.44 with 58,403 million shares trading.
RTAC has a beta of 0.28, meaning it tends to be less sensitive to market movements. RTAC has a correlation of 0.16 to the broad based SPY ETF.
RTAC has a market cap of $325.32 million. This is considered a Small Cap stock.
RTAC has underperformed the market in the last year with a return of -1.7%, while the SPY ETF gained +17.8%. In the last 3 month period, RTAC fell short of the market, returning +0.1%, while SPY returned +3.2%. However, in the most recent 2 weeks RTAC has outperformed the stock market by returning -0.3%, while SPY returned -1.0%.
RTAC support price is $10.39 and resistance is $10.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RTAC shares will trade within this expected range on the day.
